New Zealand markets close in 5 hours 41 minutes

BDX Jan 2025 320.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.05000.0000 (0.00%)
As of 09:39AM EDT. Market open.
Full screen
Previous close0.0500
Open0.0500
Bid0.0000
Ask0.7500
Strike320.00
Expiry date2025-01-17
Day's range0.0500 - 0.0500
Contract rangeN/A
Volume1
Open interest166
  • Zacks

    BD (BDX) Up on Efforts to Tackle Blood Culture Vial Shortage

    BD (BDX) faces a shortage of blood culture vials due to supplier issues. It is ramping up production and collaborating with the FDA to ensure patient care remains unaffected.

  • PR Newswire

    BD Statement on Supplier Issue Impacting BD BACTEC™ Blood Culture Vials

    BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement related to a U.S. FDA letter to health care providers regarding the supply of blood culture vials:

  • PR Newswire

    BD Surpasses Scope 1 and 2 Reduction Milestones for FY 2023

    BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has surpassed its Scope 1 and 2 science-based greenhouse gas (GHG) emissions reduction targets for FY 2023 by 5 percentage points and received approval for near and long-term science-based emissions reduction targets from the Science Based Target initiative (SBTi)[1]. This furthers the company's progress toward its goal to reach net zero GHG emissions across its value chain by FY 2050.